Medincell SA (MEDCL) — Strategic Asset Allocation Index
Medincell SA (MEDCL) has a Strategic Asset Allocation Index of 43.2% as of March 2021. Strategic assets (PP&E of €3.85 Million plus long-term investments of €-) total €3.85 Million, measured against net assets of €8.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Medincell SA's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Medincell SA Strategic Asset Allocation Index (2016–2021)
This chart shows how Medincell SA's Strategic Asset Allocation Index has evolved across 3 annual periods from 2016 to 2021. As of March 2021, the index stands at 43.2%, representing strategic assets of €3.85 Million against net assets of €8.92 Million EUR. For live market cap and overall valuation, see Medincell SA (MEDCL) market capitalisation.
Annual Strategic Asset Allocation Index for Medincell SA (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Medincell SA from 2016 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Medincell SA for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.2% | €3.85 Million | €3.85 Million | €- | €8.92 Million | ▼ -20.2 pp |
| 2019 | 63.4% | €3.96 Million | €3.32 Million | €640.00K | €6.24 Million | ▼ -50.2 pp |
| 2016 | 113.6% | €1.50 Million | €1.50 Million | €6.00K | €1.32 Million | — |